PortfoliosLab logoPortfoliosLab logo
CLOV vs. ALHC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLOV vs. ALHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Alignment Healthcare Holdings, LLC (ALHC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLOV achieves a 58.72% return, which is significantly higher than ALHC's -30.94% return.


CLOV

1D
-4.85%
1M
37.64%
YTD
58.72%
6M
49.80%
1Y
17.67%
3Y*
61.60%
5Y*
-16.04%
10Y*

ALHC

1D
2.56%
1M
-32.68%
YTD
-30.94%
6M
-28.55%
1Y
-12.06%
3Y*
29.23%
5Y*
-10.26%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLOV vs. ALHC - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CLOV
Clover Health Investments, Corp.
58.72%-25.40%230.85%2.43%-75.01%-50.99%
ALHC
Alignment Healthcare Holdings, LLC
-30.94%75.56%30.66%-26.79%-16.36%-18.78%

Correlation

The correlation between CLOV and ALHC is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Mar 29, 2021

0.33

Fundamentals

Market Cap

CLOV:

$1.95B

ALHC:

$2.91B

EPS

CLOV:

-$0.11

ALHC:

$0.10

PS Ratio

CLOV:

0.87

ALHC:

0.66

PB Ratio

CLOV:

5.74

ALHC:

14.05

Total Revenue (TTM)

CLOV:

$2.21B

ALHC:

$4.26B

Gross Profit (TTM)

CLOV:

$939.14M

ALHC:

$365.25M

EBITDA (TTM)

CLOV:

-$55.21M

ALHC:

$66.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLOV vs. ALHC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
CLOV Risk / Return Rank: 4949
Overall Rank
CLOV Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 5050
Sortino Ratio Rank
CLOV Omega Ratio Rank: 5050
Omega Ratio Rank
CLOV Calmar Ratio Rank: 4848
Calmar Ratio Rank
CLOV Martin Ratio Rank: 4747
Martin Ratio Rank

ALHC
ALHC Risk / Return Rank: 2929
Overall Rank
ALHC Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
ALHC Sortino Ratio Rank: 2929
Sortino Ratio Rank
ALHC Omega Ratio Rank: 2929
Omega Ratio Rank
ALHC Calmar Ratio Rank: 3232
Calmar Ratio Rank
ALHC Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. ALHC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Alignment Healthcare Holdings, LLC (ALHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLOVALHCDifference

Sharpe ratio

Return per unit of total volatility

0.26

-0.25

+0.51

Sortino ratio

Return per unit of downside risk

0.88

-0.02

+0.90

Omega ratio

Gain probability vs. loss probability

1.11

1.00

+0.11

Calmar ratio

Return relative to maximum drawdown

0.34

-0.26

+0.59

Martin ratio

Return relative to average drawdown

0.62

-0.79

+1.40

CLOV vs. ALHC - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 0.26, which is higher than the ALHC Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of CLOV and ALHC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CLOVALHCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.26

-0.25

+0.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.16

-0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.18

-0.07

-0.11

Drawdowns

CLOV vs. ALHC - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, which is greater than ALHC's maximum drawdown of -83.61%. Use the drawdown chart below to compare losses from any high point for CLOV and ALHC.


Loading charts...

Drawdown Indicators


CLOVALHCDifference

Max Drawdown

Largest peak-to-trough decline

-97.19%

-83.61%

-13.58%

Max Drawdown (1Y)

Largest decline over 1 year

-55.50%

-44.14%

-11.36%

Max Drawdown (3Y)

Largest decline over 3 years

-64.73%

-50.33%

-14.40%

Max Drawdown (5Y)

Largest decline over 5 years

-97.19%

-83.61%

-13.58%

Current Drawdown

Current decline from peak

-83.16%

-49.98%

-33.18%

Average Drawdown

Average peak-to-trough decline

-76.62%

-52.24%

-24.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.54%

14.34%

+16.20%

Volatility

CLOV vs. ALHC - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 22.50% compared to Alignment Healthcare Holdings, LLC (ALHC) at 20.82%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than ALHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLOVALHCDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.50%

20.82%

+1.68%

Volatility (6M)

Calculated over the trailing 6-month period

39.35%

39.73%

-0.38%

Volatility (1Y)

Calculated over the trailing 1-year period

68.61%

49.12%

+19.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

88.12%

62.57%

+25.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.66%

62.93%

+22.73%

Dividends

CLOV vs. ALHC - Dividend Comparison

Neither CLOV nor ALHC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLOV vs. ALHC - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Alignment Healthcare Holdings, LLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00B1.20B20222023202420252026
749.19M
1.24B
(CLOV) Total Revenue
(ALHC) Total Revenue
Values in USD except per share items

CLOV vs. ALHC - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and Alignment Healthcare Holdings, LLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
92.4%
0
Portfolio components
CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.

ALHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported a gross profit of 0.00 and revenue of 1.24B. Therefore, the gross margin over that period was 0.0%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.

ALHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported an operating income of 15.50M and revenue of 1.24B, resulting in an operating margin of 1.3%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.

ALHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported a net income of 11.42M and revenue of 1.24B, resulting in a net margin of 0.9%.


Frequently Asked Questions


CLOV and ALHC have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLOV has higher volatility (22.50%) compared to ALHC (20.82%). In terms of maximum drawdown, CLOV dropped -97.19% vs ALHC's -83.61%.

CLOV currently has the higher Sharpe Ratio (0.26 vs -0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLOV and ALHC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer